Baillie Gifford - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,120
-43.5%
3720.0%0.00%
Q4 2022$3,753
-53.1%
3720.0%0.00%
Q3 2022$8,000
-11.1%
3720.0%0.00%
Q2 2022$9,0003720.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$197,709,00022.51%
Redmile Group, LLC 12,957,222$758,127,00017.24%
Grosvenor Holdings, L.L.C. 1,037,256$60,690,0006.28%
Casdin Capital, LLC 3,400,000$198,934,0005.61%
Ally Bridge Group (NY) LLC 270,000$15,798,0005.52%
DAFNA Capital Management LLC 372,160$21,775,0005.48%
Tri Locum Partners LP 142,032$8,310,0003.27%
Kynam Capital Management, LP 95,561$5,591,0002.99%
Artal Group S.A. 1,800,000$105,318,0002.86%
Bellevue Group AG 3,775,736$220,918,0002.28%
View complete list of FATE THERAPEUTICS INC shareholders